共 48 条
[1]
Neuhouser ML(2015)Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials JAMA Oncol 1 611-621
[2]
Aragaki AK(2004)National use of postmenopausal hormone therapy: annual trends and response to recent evidence JAMA 291 47-53
[3]
Prentice RL(2007)The decrease in breast-cancer incidence in 2003 in the United States N Engl J Med 356 1670-1674
[4]
Hersh AL(2022)Cancer statistics, 2022 CA Cancer J Clin 72 7-33
[5]
Stefanick ML(2019)Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence Lancet 394 1159-1168
[6]
Stafford RS(2017)underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults Lancet 390 2627-2642
[7]
Ravdin PM(1975)Association of exogenous estrogen and endometrial carcinoma N Engl J Med 293 1164-1167
[8]
Cronin KA(2017)Demographic changes in breast cancer incidence, stage at diagnosis and age associated with population-based mammographic screening J Surg Oncol 115 517-522
[9]
Howlader N(2002)Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial JAMA 288 321-333
[10]
Siegel RL(2003)Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial JAMA 289 3243-3253